Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Zcash (ZEC) To Dip Further? Key Breakdown Signals Potential Downside Move

Zcash (ZEC) To Dip Further? Key Breakdown Signals Potential Downside Move

CoinsProbeCoinsProbe2025/11/22 11:18
By:Nilesh Hembade

Date: Sat, Nov 22, 2025 | 07:10 AM GMT

The cryptocurrency market continues to face heavy selling pressure as both Bitcoin (BTC) and Ethereum (ETH) plunged over 1.5% in the past 24 hours. The correction triggered more than $1.69 billion in liquidations across the market, with long positions taking the biggest hit — over $1.45 billion wiped out during the same period.

The high volatility has impacted major altcoins, including the privacy token Zcash (ZEC), which has dropped more than 23% following a key structure breakdown, hinting at additional downside ahead.

Zcash (ZEC) To Dip Further? Key Breakdown Signals Potential Downside Move image 0 Source: Coinmarketcap

Ascending Triangle Breakdown

On the 4-hour chart, ZEC had been consolidating within an ascending triangle — a formation that typically supports bullish continuation when price breaks upward. However, when buyers fail to maintain momentum, these patterns can break to the downside with significant force.

After multiple failed attempts to break above the neckline resistance at around $716, ZEC lost strength and broke below the ascending trendline and the 50-period moving average near $633. This breakdown resulted in strong selling pressure, dragging the price sharply lower to the current zone around $503.

Zcash (ZEC) To Dip Further? Key Breakdown Signals Potential Downside Move image 1 Zcash (ZEC) 4H Chart/Coinsprobe (Source: Tradingview)

The move represents a clear structural shift, indicating that bullish momentum has weakened and sellers have taken control.

What’s Next for ZEC?

The key question now is whether ZEC will attempt a retest of the broken support trendline, which has now turned into resistance. If the price fails to reclaim this level, the bearish trajectory may continue and push ZEC toward the next major target around $366 — the measured breakdown projection from the triangle, which still sits roughly 28% below current levels.

On the other hand, if bulls regain control and push the price back above the 50 MA, a temporary relief bounce could emerge. However, unless ZEC reclaims the triangle structure convincingly, any recovery may risk becoming a fakeout rather than a real reversal.

For the moment, market sentiment and technical structure both lean bearish, suggesting caution is warranted.

0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!

You may also like

Polkadot Latest Updates: ECB Raises Concerns: Cryptocurrency and Stock Market Downturns Resemble Dot-Com Bubble Threats

- ECB warns U.S. equity/crypto corrections threaten stability, urging central banks to retain rate-cut flexibility amid market volatility. - JPMorgan links crypto ETF outflows to retail investor behavior, noting $4B November sales contrast with $96B equity ETF inflows. - U.S. Treasury downplays recession risks, citing 2026 growth optimism despite shutdown impacts and services-driven inflation. - MSCI highlights tech valuation risks akin to dot-com era, while DeFi faces $12B liquidity crisis with 95% capita

Bitget-RWA2025/11/23 20:30
Polkadot Latest Updates: ECB Raises Concerns: Cryptocurrency and Stock Market Downturns Resemble Dot-Com Bubble Threats

Novartis Increases 2030 Growth Projections Despite Analysts' Concerns About Patent Threats

- Novartis raised 2030 sales growth targets to 5-6% annually, driven by high peak sales expectations for oncology drugs Kisqali and Scemblix. - CEO Vas Narasimhan highlighted eight de-risked drugs with $3-10B peak potential, but analysts warned of patent expirations and uncertain pipeline progress beyond 2030. - Shares rose 0.5% post-announcement, while Exact Sciences surged 17% on its $105/share acquisition by Abbott and Samsung Biologics saw a 71% valuation re-rating after spin-off. - J.P. Morgan caution

Bitget-RWA2025/11/23 20:30
Novartis Increases 2030 Growth Projections Despite Analysts' Concerns About Patent Threats

Institutional Blockchain Integration: Blockdaemon and 21shares Bridge Traditional Finance and Web3 through the Canton Network

- Blockdaemon's Institutional Vault now supports Canton Coin, enabling secure custody and tokenization for institutions on the Canton Network. - 21shares launched a Canton Coin ETP on Euronext, offering investors institutional-grade exposure to privacy-focused blockchain innovation. - Canton Network's architecture, backed by J.P. Morgan and Goldman Sachs , facilitates secure, interoperable transactions while maintaining regulatory compliance. - Partnerships between blockchain infrastructure providers and t

Bitget-RWA2025/11/23 20:30
Institutional Blockchain Integration: Blockdaemon and 21shares Bridge Traditional Finance and Web3 through the Canton Network